Regulacje i polityka gospodarcza · 10/11/1999

Licensing Opportunity and/or Cooperative Research and Development Agreement (``CRADA'') Opportunity; Certain Live Attenuated Respiratory Syncytial Viruses (RSV) and Parainfluenza Viruses (PIV) for Use as Human Vaccines

The National Institutes of Health (NIH) is seeking Licensee(s) and/or a commercial collaborator(s) to further develop, test, and commercialize as live attenuated vaccines certain recombinant RSV and PIV strains and associated intellectual property developed in the Laboratory of Infectious Diseases (LID), Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID).